Tracers / [18F]NaBF4
[18F]NaBF4
Also written as [F-18]NaBF4
- Radionuclide
- F-18 t½ 109.77 min
- Modality
- Therapy
- Production route
- —
- Stage
- Reported once
- Syntheses indexed
- 1
What it is
- Compound class
- Inorganic fluoroborate salt (NaBF4, sodium-iodide symporter substrate)
- Target / mechanism
- Uptake via sodium-iodide symporter (NIS) expressed on thyroid cell surface PMID 32932575
- Clinical application
- PET-based boron quantification for BNCT treatment planning in thyroid disease/cancer PMID 32932575
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — | — | SPE | 36 yes | 98 | NaBF4 | 32932575 2020 Cells |
Need this precursor?We can point you to suppliers for [18F]NaBF4, or handle the enquiry for you.
Get in touchNotes
Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 32932575. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.